| Description | Topiroxostat (FYX-051) is a selective xanthine oxidase inhibitor developed for treatment and management of hyperuricemia and gout. |
| Target activity | XOR:5.3 nM |
| Synonyms | 托匹司他, FYX-051 |
| molecular weight | 248.24 |
| Molecular formula | C13H8N6 |
| CAS | 577778-58-6 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 11 mg/mL (44.31 mM) |
| References | 1. Sato T, et al. Bioorg Med Chem Lett. 2009 Nov 1;19(21):6225-9. |